Evidence map›Paper›PMID 40057920›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2025

Targeted photodynamic elimination of HER2

Yi Li, Jian Hou, Jun Wan, Qinglian Liu, Lei Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yi LiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Jian HouInstitute of Molecular Physiology, Shenzhen, Shenzhen Bay LaboratoryGuangdong, 518107, China.
Jun WanGreater Bay Biomedical InnoCenter, Shenzhen, Shenzhen Bay LaboratoryGuangdong, 518107, China.
Qinglian LiuDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Lei ZhouInstitute of Molecular Physiology, Shenzhen, Shenzhen Bay LaboratoryGuangdong, 518107, China. zhoulei@szbl.ac.cn.ORCID http://orcid.org/0000-0002-3838-1836

Funding

Structural and Functional Studies of Hsp70 Molecular ChaperonesR01GM098592 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Qinglian Liu · 2013 to 2026
$4.3M
National Natural Science Foundation of China 32171150NIH HHS R01GM098592
6 · The paper itself

Abstract

Breast cancer has emerged as the leading cause of cancer death in women worldwide. The high recurrence and metastasis rates of malignant tumors impose significant limitations on existing mainstream treatments, including surgery, chemotherapy, and radiotherapy. Photodynamic therapy (PDT) is a clinically validated approach for cancer treatment. PDT requires three elements, photosensitizer, light, and oxygen, and mainly relies on the production of singlet oxygen (

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesPhotochemotherapyPhotosensitizing AgentsRecombinant Fusion ProteinsTrastuzumabCell Line, TumorCell SurvivalFemaleHumansSARS-CoV-2Singlet OxygenERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesPhotosensitizing AgentsRecombinant Fusion ProteinsSinglet OxygenTrastuzumabBreast cancerPhotodynamic therapySinglet oxygenSOPP3Trastuzumab

Identifiers

PMID40057920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.